Health In Tech, Inc. (HIT)
NASDAQ: HIT · Real-Time Price · USD
0.5623
-0.0130 (-2.26%)
At close: Oct 23, 2026, 4:00 PM EDT
0.5735
+0.0112 (1.99%)
After-hours: Oct 23, 2026, 4:48 PM EDT
Health In Tech Stock Forecast
HIT's stock price has decreased by -79.33% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 3 analysts polled by S&P Global, Health In Tech stock has a consensus rating of "Buy" and an average price target of $3.12. The average 1-year stock price forecast is 454.86% higher than the current stock price, while the lowest is $1.25 (+122.30%) and the highest is $4.10 (+629.15%).
Price Target: $3.12 (+454.86%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Health In Tech stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Reiterates $3 → $1.25 | Buy | Reiterates | $3 → $1.25 | +122.30% | Oct 3, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Reiterates $4 | Buy | Reiterates | $4 | +611.36% | Oct 1, 2026 |
Financial Forecast
Revenue This Year
31.79M
from 33.33M
Decreased by -4.61%
Revenue Next Year
54.12M
from 31.79M
Increased by 70.22%
EPS This Year
-0.12
from 0.02
EPS Next Year
0.10
from -0.12
EPS and Forward PE are based on non-GAAP adjusted numbers.